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We compared the efficacy ofChinese traditional treatment for mild hypertension with that of
a standard Western medical regimen in a group of 50 well-matched patients (24 allocated to
Western medicine and 26 to Chinese traditional medicine) with mild hypertension (diastolic
blood pressure 90-104 mmHg). Those receiving Western therapy were treated in a stepped-
care fashion with dihydrochlorothiazide and atenolol. Those in the Chinese traditional therapy
group received one of two mixtures of nine herbs and other ingredients, depending on
symptoms at initial evaluation. Blood pressure dropped significantly in both groups afteronly a
few days on therapy. After 19 days on treatment, the group receiving Western therapyhad a fall
in blood pressure from 168.2/96.3 mmHg to 137.3/76.7 mmHg (p < 0.01), while those on
Chinese traditional therapy fell from 168.2/95.9 mmHg to 146.4/80.5 mmHg (p < 0.01). The
fall in blood pressure was significantly greater, however, in those given Western therapy. The
relief of existing symptoms or development of possible drug side effects was similar in both
groups, except for nocturia, occurring more often in the group treated with Western therapy.
We conclude that Western therapy is more effective in reducing blood pressure as compared
with Chinese traditional therapy, but effective control ofblood pressure in mild hypertensives is
possible with either form oftreatment.
INTRODUCTION
The effective treatment ofhypertension is essential for preventing related compli-
cations, in particular coronary heart disease, stroke, congestive heart failure, and
renal disease. Although these sequelae of hypertension have been on the decline in
many Western nations over the past few decades [1], they have become increasingly
important causes of morbidity and mortality in China [2], where the estimated
prevalence rates ofhypertension (diastolicblood pressure of95 mmHgorhigher) are
3 to 9 percent with an additional 4 percent having a diastolic blood pressure of
between 90 and 95 mmHg [3]. Recent surveys of factory workers in China's Hunan
province show the prevalence of hypertension (as defined by a diastolic blood
pressure greater than or equal to 90 mmHg) to be approximately 7 percent, and that
ofthe general population slightly higher [4]. Since 1950, the prevalence ofhyperten-
sion throughout China has increased [5], though blood pressures in urban areas and
in northern parts of China are higher than those in rural and southern regions [6].
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Other risk factors forcoronarydisease, especially serum cholesterol [7] and cigarette
smoking, have also increased dramatically over the past few years.
Although Western approaches to treating hypertension in China are becoming
more popular, many medical practitioners, especially in rural areas, still use herbal
preparations as the primary mode of treatment. It has previously been shown that
drug therapy employing Western medicine is superior to Chinese traditional treat-
ment[8] for moderate and severe hypertensives. But it remains to be shown whether
traditional treatment may be as effective for mild hypertensives, who comprise a
substantial proportion of the hypertensive population. If so, such treatment, which
could have fewer side effects, might be used for those patients. Western treatment
could be reserved for those whose hypertension is more severe.
In this report, we compare the efficacy and side-effect profile of a stepped-care
Western medical regimen with a symptom-based Chinese traditional prescription in
the treatment ofpatients with mild hypertension.
MATERIALS AND METHODS
Thirteen hundred retired factory workers in the city of Changsha within Hunan
province of the People's Republic of China were screened for hypertension. Three
independent blood pressure readings at different times of the day or on different
days were obtained by a group of trained physicians and nurses. An individual was
considered hypertensive iftwo out ofthree readings were abnormal (diastolic blood
pressure of95mmHg orgreater orsystolic blood pressure of 160 mmHg or greater).
Tenpercent(130) were found to behypertensive, and 70 agreed to participate in the
study. Of these, 64 were systematically allocated to either Western medical or
Chinese traditional treatment,dependingonwhether the assigned screening number
was odd or even [8]. Fifty of these patients had blood pressure levels in the mild
hypertension range (diastolic blood pressure between 90-104 mmHg) after a four-
day washout period to eliminate any effects of medications the subjects were
currently taking (the most commonly used medication prior to recruitment was a
mixture in capsule form of the herb rauwolfia alkaloid with a sedative and diuretic).
Thesepatients form the cohort studied in this report. Fourteen other patients (eight
patients fromgroup 1 and sixpatients fromgroup 2) were excluded from the analysis
because ofnotmeeting thecriteria for mildhypertension (diastolic blood pressure of
90-104mmHg) at the measurementtakingfollowing the washout period (day 4).
Theprotocol for the Western treatment is shown in Table 1, and the protocol for
the Chinese traditional treatment is described in Table 2. Those receiving Western
treatment were put on a standard stepped-care regimen of dihydrochlorothiazide
followed by atenolol, as is used at the Hypertension Clinic of the First Affiliated
Hospital in Hunan. Those allocated to Chinese traditional (primarily herbal) treat-
ment were given either prescription A orprescription B (there were approximately
equal numbers ofpatients receiving each prescription), based on which category of
symptomstheyfitbest. Thisassignment wasmade after discussion by a panel ofthree
physicians trained in the use of Chinese traditional medicine. Symptom criteria for
each of the prescriptions were provided by a panel of traditional medicine experts
from theBeijing National Traditional Medicine Institute, aswere suggestions for the
specific traditional Chinese medicine mixtures, which represent the traditional
ingredients of choice used to treat hypertension patients in China. The appropriate
mixture ofherbs and otheringredientswas boiled in 500 ml ofwater for 30 minutes,
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TABLE 1
Drug Protocol for Western Therapy
Day 1-4 (washout period) No therapy
Day 5-11 Dihydrochlorothiazide
(25 mg twice daily)
Day 12-18 If DBP < 90 mmHg No change
If DBP > 90 mmHg Atenolol
or SBP > 160 mmHg (25 mg three times daily added)
Day 19-24 IfDBP < 90 mmHg No change
IfDBP > 90 mmHg Double dosage ofboth drugs
or SBP > 160 mmHg
DBP, diastolic blood pressure
SBP, systolic blood pressure
as previously described [8], producing a liquor which the patient drank. Additional
liquor produced by reboiling the same mixture in another 500 ml ofwater was also
ingested by the patient. The mixture was given twice daily. The particular mixture
given a patient receiving traditional treatment did not change; however, two addi-
tional ingredients, earthworm (Lumbricus) and achyranthis root (Radix achyranthis
bidentatae) were added if normotensive levels were not achieved from the original
mixture.
In both patient groups, a physical examination and laboratory tests, including an
electrocardiogram, were done prior to day 1 of the study in the hospital serving the
factory and at designated intervals in the clinic throughout the study. Blood pressure
and pulse readings were taken the first day, the fourth day, the seventh day, the
fourteenth day, and the twenty-third day, and, of three readings on each of these
days, the latter two were averaged to obtain the recorded pressure. Each time, the
readings were taken at 4:00 P.M. by three physicians in the medical outpatient clinic
TABLE 2
Drug Protocol for Chinese Traditional Therapy
Day 1-4 (Washout period) No therapy
Day 5-24 Active therapy ofprescription A or B according to traditional diagnosis, depending on
symptoms
Prescription A (gyanyan kan)
Representative Symptoms: Strong pulse, loud voice, easily irritated, constipation/dry stool, yellow urine,
dry tongue with layer ofyellow, and obesity
Ingredients: Oyster shell (Concha ostreae), magnetite (Magnetitum), earthworm (Lumbricus), rehmannia
root (Radixrehmanniae), achyranthis root (Radixachyranthis bidentatae), grass-leaved sweet flag
rhizome (Rhizoma acorigraminei), prunella/self-heal spike (Spicaprunellae), chrysanthemum (Flos chry-
santhemi), and water-plantain tuber (Rhizoma alismatis)
Prescription B (singyin shu)
Representative Symptoms: Rapid and thready pulse, loose stool, excessive urine, red tongue, and under-
weight
Ingredients: Siberian solomon seal rhizome (Rhizomapolygonati), lucid ligustrum fruit (Fructus ligustri
lucidi), wolfberry fruit (Fructus lycii), eucommia bark (Cortexeucommiae), mulberry mistletoe (Ramulus
loranthi), philodendron bark (Cortexphilodendron), tetrandra root (Radixstephaniae tetrandrae), Chinese
angelica root (Radixangelicae sinensis), and pueraria/kudzu vine root (Radixpuerariae)82 WONG ET AL.
at the factory. All participants were fully ambulatory and were instructed not to
modify their diets.
Baseline characteristics, including demographic, laboratory, and pre-treatment
blood pressure and pulse readings were compared between treatment groups using
the Student's t-test for unpaired samples. Differences between groups in blood
pressure and heart ratechanges frompost-washout baseline (day 4) to days 7, 14, and
23, and serum potassium from day 4 to day 23 were assessed similarly. Analysis of
covariance was used toadjust for the effects ofage, sex, baseline blood pressure, and
Quetelet index(kg/M2).Ap-value of <0.05was considered statistically significant for
differences in treatment efficacy. The Fisher's exact test and chi-square test of
proportions were used to compare the frequency of symptoms individually and
overall, respectively, between the two medication groups at the initial observation
period(days1-4) and atpost-treatment (days 28-30).
RESULTS
Fiftypatientswithmildhypertension after thefour-daywashout period completed
the study. There were 24 in the Western medication group and 26 in the Chinese
traditionalmedicationgroup(ofwhom 11 received thegyanyan kan prescription and
15 thesingyin shu prescription). Ofthe 24 patients in the Western medicine group,
secondary therapy of atenolol was given to seven patients (29 percent). Of the 26
patients in the Chinese traditional therapygroup, nine (35 percent, all in the singyin
shuprescription group) had the two additional ingredients, earthworm(Lumbricus)
andRadixachyranthisbidentatae, added to their initial prescription.
Table 3 compares the baseline characteristics (demographic, laboratory, physical
examination, andpre-treatment bloodpressure and pulse measurements) ofthe two
treatment groups. No significant differences in any of these characteristics are
demonstrated between the two groups.
Table4showsthe absolutevaluesofsystolic and diastolicblood pressure and pulse
rate at the end ofwashout (day 4) and during treatment (day 7, day 14, and day 23)
forboth ofthe treatmentgroups. The meanchanges from the baseline (at day 4) are
shown in parentheses. The corresponding absolute values and mean changes of
serumpotassium fromday 4 today23 are also shown. Also indicated are whether the
changes from baseline to each of the three treatment recordings are significant
within each treatment group, as well as whether the changes from baseline to each
treatment period differ between groups (e.g., whether the efficacy of treatments
differed by days 7, 14, and 23).
Clinically important decreases in both systolic and diastolic blood pressure are
seen in those receiving either Western medical or traditional Chinese therapy. For
both groups, systolic and diastolic blood pressure dropped significantly (p < 0.01)
frompost-washout baseline at four days to each of the measurements on treatment
(seven days, 14 days, and 23 days). Although the traditional medicine group was
effective in reducing blood pressure to normotensive levels (mean systolic/diastolic
blood pressure of 146.4/80.5 mmHg by the twenty-third day), significantly greater
reductions in both systolic and diastolic blood pressure are seen in the Western
stepped-care medication group by both the fourteenth and the twenty-third day. By
the twenty-third day, systolic blood pressure in the Western group had dropped an
average of 30.9 mmHg, compared to 21.8 mmHg in the herbal group (p = 0.05).
Corresponding drops in diastolic pressure were 19.7 mmHg and 15.4 mmHg,
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TABLE 3
Baseline Characteristics:
Mean (SD) or Percentage, by Group
(p < 0.05 comparing means or proportions between groups)
Western Medicine Herbal Medicine
(Group 1) (Group 2)
(n = 24) (n = 26)
% Male 42 (n = 10) 46 (n = 12)
Age (years) 62.5 + 7.9 64.0 ± 9.0
Weight (kg) 57.7 + 6.4 55.8 ± 7.9
Height (cm) 161.9 + 9.0 163.5 + 9.0
Serum K+ (mEq/L) (day 1) 4.12 ± 0.44 3.98 ± 0.50
Serum K+ (mEq/L) (day 4) 3.90 ± 0.35 3.94 + 0.37
BUN (mg/dl) 14.9 ± 4.2 14.7 ± 4.1
No. with >2+ proteinuria 2 2
No. with definite left ventricular hypertrophy 1 2
by ECG
No. with abnormal sinus tachycardia 4 4
changes
Day 1 systolic blood pressure (mmHg) 174.4 ± 16.5 168.5 ± 15.4
Day 1 diastolic blood pressure (mmHg) 98.1 ± 7.7 96.6 ± 9.5
Day 1 pulse (beats/minute) 76.9 ± 7.9 77.0 ± 10.2
Day 4 systolic blood pressure (mmHg) 168.2 ± 16.2 168.2 ± 17.6
Day 4 diastolic blood pressure (mmHg) 96.3 ± 5.4 95.9 ± 6.0
Day4 pulse (beats/minute) 76.7 ± 8.9 74.8 ± 8.0
respectively (p < 0.05). Except for a rise in heart rate from the seventh to the
fourteenth day in the Western medicine group, there were no significant on-
treatment changes in heart rate within or between groups. A highly significant fall
(from 4.12 to 3.90 mEq/l,p < 0.01) in serum potassium during the 19-day treatment
period occurred in the Western medicine group; serum potassium levels stayed
essentially the same in the Chinese traditional therapy group, however.
Results from the analysis ofcovariance procedures (Table 5) done to compare the
efficacy of treatment group in reducing systolic blood pressure and diastolic blood
pressure from the post-washout baseline (day 4) to each of the treatment period
recordings (day 7, day 14, and day 23) were generally consistent with the initial
results shown above. After accounting for the effects of age, sex, baseline blood
pressure (systolic or diastolic at day 4), and Quetelet index (kg/M2), the superior
efficacy of Western treatment is statistically significant for analyses predicting
changes in systolic blood pressure from baseline to days 7, 14, and 23, and for
diastolic blood pressure from baseline to days 14 and 23. Independent of treatment
effects, baseline systolic blood pressure (at day 4), but not baseline diastolic blood
pressure, was significantly correlated (p < 0.01) with subsequent changes in blood
pressure by day 7, day 14, and day 23. There was a weak relationship (p < 0.10) of
age with subsequent changes in systolic blood pressure by day 7 and changes in
diastolic blood pressure by day 23. No consistent effects of sex or Quetelet index on
response to treatment were noted.
The number of patients developing each of 14 adverse symptoms within each of
the treatment groups during the treatment period, and the number of patientsWONG ET AL.
TABLE 4
Treatment Changes from Baseline and Between Groups, byTreatment Period
Baseline Treatment
Group (Day 4) (Day 7) (Day 14) (Day 23)
Systolic Blood Pressure
(mmHg)
Western
(Change from day 4)
(n = 24)
Herbal
Change from day 4)
(n = 26)
168.2 151.9 146.1 137.3
(-16.3) (-22.1) (-30.9)
** ** **
168.2 159.7 157.4 146.4
(-8.5) (-10.8) (-21.8)
p =0.1 ** **
Significance oft-test
comparingblood pressure change
between Western/Herbal
treatments
N.S. * p = 0.05
Diastolic Blood Pressure
(mmHg)
Western
(Change from day4)
(n = 24)
Herbal
(Change from day 4)
(n = 26)
96.3 86.5 80.0 76.7
(-9.8) (-16.3) (-19.6)
** ** **
95.9 88.3 85.2 80.5
(-7.6) (-10.7) (-15.4)
** ** **
Significance oft-test
comparing blood pressure change
between Western/Herbal treatments
Heart Rate
(beats/minute)
Western
(Change from day 4)
(n = 24)
Herbal
(Change from day 4)
(n = 26)
76.7 74.9 82.1 73.6
(-1.8) (5.4) (-3.1)
N.S. * N.S.
74.8 75.2 75.8 74.4
(0.4) (1.0) (-0.4)
N.S. N.S. N.S.
Significance oft-test
comparing heart rate change
between groups
Serum Potassium
(K+) (mEq/1)
Western
(Change from day 4)
(n = 24)
Herbal
(Change from day 4)
(n = 26)
N.S. N.S. N.S.
4.12
3.98
3.90
(-0.22)
**
3.94
(-0.04)
N.S.
Significance oft-test
comparing serum potassium
change between groups
N.S.
*p < 0.05
**p < 0.01
Compared with level at day 4, or comparing changes in blood pressure from baseline, between groups,
by the indicated day oftreatment
N.S., not significant
N.S.
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TABLE 5
Multivariable Analysis ofTreatment Group Effect on Blood Pressure Change by Period, Adjusting for
Baseline Blood Pressure, Age, Sex, and Quetelet Index
Change from Baseline (Days) to
(Fstatistics)
Day 7 Day 14 Day23
Systolic Blood Pressure (SBP)
Treatment Group 4.17* 6.88* 4.69*
Baseline SBP 8.24** 12.23** 17.66**
Age 3.27 2.69 1.34
Sex 0.06 1.15 0.004
Quetelet Index 2.00 1.24 0.15
(weight/height2)
Diastolic Blood Pressure (DBP)
Treatment Group 2.25 6.68* 4.81*
Baseline DBP 0.01 2.19 0.08
Age 0.02 1.56 3.93
Sex 0.01 0.85 0.61
Quetelet Index 1.85 0.39 0.11
(weight/height2)
*p < 0.05
**p < 0.01 for the test of a treatment group effect on change in systolic or diastolic blood pressure or
effect ofbaseline blood pressure on change in blood pressure for indicated period
relieved of symptoms during this period are shown in Table 6. Comparisons of
proportions of individuals with each symptom between groups by the Fisher's exact
test demonstrated onlythe incidence ofnocturia to be significantly (p < 0.05) more
common among the group receiving Western medication during the initial observa-
tion period (days 1-4). No other differences in the relief or incidence of symptoms
were noted, although the prevalence of most side effects appeared to decrease in
both groups.
DISCUSSION
The results ofthis investigation demonstrate that either a stepped-care regimen of
Western therapy or traditional Chinese treatment are effective in reducing blood
pressure to normotensive levels in those with mild hypertension. Western therapy,
however, is shown to be significantly more efficacious compared to traditional
Chinese therapy, resulting in greater decreases in both systolic and diastolic blood
pressure after the firstweekon treatment. Furthermore, both regimenswere equally
well tolerated and appeared to reduce patient complaints. Only nocturia was more
common in the Western group (who received the thiazide diuretic).
Although neitherblinded randomization norplaceboswere used in this study, it is
felt that the systematic allocation, alternating assignment to either Westem or
Chinese traditional treatment groups prior to blood pressure measurement, did
provide for comparable study groups. Both groups, in fact, were quite similar in all
baseline characteristics. Of those originally eligible to enter the study, no patient
refused treatmentbecause ofassignment to a specific treatment group. Among those
receiving traditional treatment, although the mechanisms of action are felt to be
different for prescriptions A and B, no differences in efficacy were found. Choice of
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TABLE 6
Incidence and Reliefof Symptoms During Treatment Period
aIncidence Relief
Western Medicine Chinese Traditional Western Medicine Chinese Traditional
(Group 1) (Group 2) (Group 1) (Group 2)
(n = 24) (n = 26) (n = 24) (n = 26)
Stuffiness 0 0 2 (29) 1 (14)
Palpitation 0 2 (10) 3 (50) 1 (17)
Shortness ofbreath 0 0 0 2 (33)
Edema 0 0 0 3 (75)
Nocturia *4 (36) 0 2 (15) 2 (13)
Headache 0 0 3 (25) 6 (50)
Dizziness 0 0 1 (8) 1(7)
Sleeplessness 0 0 3 (30) 3 (23)
Blurred vision 2 (14) 0 0 1 (14)
Sexual dysfunction 0 1(4) 0 0
Nightmares 0 2 (11) 1(14) 2 (25)
Weakness oflimbs 3 (15) 2 (8) 0 0
Muscle cramping 0 1(5) 1(25) 1 (17)
Rash 0 0 3 (43) 2 (50)
aNumber ofcases with symptoms developing or being relieved during the treatment period; numbers in
parentheses indicate the percentage ofcaseswithout symptom at baseline who developed the symptom
during the treatment period, or those with the symptom at baseline who experienced relief of the
symptom during the treatment period.
*p < 0.05 compared to incidence in group 2
the prescriptions to use was based on the particular diagnosis and presenting
symptoms, consistentwithChinese traditionalteaching. The differentpatient charac-
teristics used in assigning a particular prescription, however, preclude making
conclusions as to which is a more effective traditional mixture for the representative
hypertensive patient.
The results of this investigation stand in dramatic contrast to our previously
reported comparison of the efficacy of Western and Chinese therapy [8]. In that
study, ayoungerpopulationwith more end-organ damage and more severe hyperten-
sion (a diastolic blood pressure at entry of 105 mmHg to 129 mmHg was used) was
seen on an inpatient basis; we found that Chinese traditional medicine was totally
ineffective, while Western treatment was successful. The reasons are not clear.
Perhaps Chinese traditional medicines may not work in patients with accompanying
clinical problems or more severe hypertension. Anotherpossible reasonwhyChinese
traditional medicine worked in this present study and not in our earlier one includes
the fact that the medications used were selected on the basis of which symptom-
based diagnosis (gyanyan kan or singyin shu) best fit the given patient allocated to
the traditional medicine group. In ourearlierprotocol, different herbswere used and
all patients received the same prescription. The regimen used in the previous report
[8] and that used here was, however, recommended by specialists in Chinese
traditional medicine [9]. The most effective traditional agents alone include the
tetrandra root (Radix stephaniae tetrandrae), eucommia bark (Cortex eucommiae),
prunella/self-heal spike (Spica prunellae), earthworm (Lumbricus), and Chinese
angelica root (Radix angelicae sinensis); however, it is unclear which agents in
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combination are most effective. Finally, there is the possibility that those allocated to
traditional therapy may have used other medications that were available to them
(Chinese persons often borrow medication from one another). We feel that this
situation is unlikely, however, since both heart rate and serum potassium levels were
similar at the start and the conclusion ofthe traditional treatment regimen. Also, our
first studywas done in the hospital, while this studywasperformed on an ambulatory
population.
We have again shown that Western medication reduces blood pressure substan-
tially more than Chinese traditional regimens. This study does demonstrate, how-
ever, that specific herbal preparations can effectively lower blood pressure in mild
hypertensives to normotensive levels with little difference in the incidence of side
effects, compared to Western drug therapy. Since many Chinese prefer to use herbal
preparations, it is now clear that these can effectively be used to treat individuals
with mild hypertension, although cost and convenience considerations must be
weighedwhen selectingwhat is the best treatment for a particular individual.
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